Rigel Pharmaceuticals Inc (RIGL)

Investing Cash Flow

$17.45M

Quarterly · Period ending: · USD

RIGL logo

RIGL Investing Cash Flow

Latest reported$17.45M
RIGL Quarterly Cash from Investing (-$22.71M → $17.45M)
High-resolution chart · PNG

RIGL investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
17,453,000
-7,975,000
-25,362,000
-33,175,000
-23,276,000
-10,552,000
-10,914,000
3,802,000
10,929,000
313,000
-6,874,000
-1,170,000
2,970,000
777,000
18,598,000
10,455,000
21,095,000
22,629,000
6,488,000
-44,397,000
-49,659,000
7,532,000
8,711,000
19,528,000
-5,234,000
24,461,000
-7,617,000
-294,000
-14,672,000
-1,073,000
2,093,000
15,855,000
-16,202,000
23,218,000
-35,240,000
7,561,000
8,356,000
-150,000
2,111,000
10,393,000
19,148,000
-6,771,000
12,750,000
30,646,000
-8,294,000
9,511,000
16,959,000
7,258,000
28,255,000
10,460,000
23,480,000
14,906,000
8,208,000
25,786,000
-108,288,000
19,079,000
23,973,000
26,185,000
17,836,000
-11,498,000
-106,977,000
37,791,000
-23,955,000
8,871,000
-62,320,000
24,001,000
-57,330,000
-5,019,000
11,561,000
20,124,000
13,846,000
32,742,000
-30,332,000
-43,226,000
9,956,000
-13,859,000
-14,745,000
10,855,000
2,721,000
436,000
2,849,000
-2,058,000
-26,528,000
13,658,000
7,855,000
2,864,000
4,367,000
8,102,000
-23,438,000
-14,836,000
-4,308,000
-32,842,000
329,000
-485,000
5,753,000
20,950,000
704,000
-7,916,000
3,648,000
7,943,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.